DE102005009217A1 - Phosphatsalze der 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexanverbindungen - Google Patents
Phosphatsalze der 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexanverbindungen Download PDFInfo
- Publication number
- DE102005009217A1 DE102005009217A1 DE102005009217A DE102005009217A DE102005009217A1 DE 102005009217 A1 DE102005009217 A1 DE 102005009217A1 DE 102005009217 A DE102005009217 A DE 102005009217A DE 102005009217 A DE102005009217 A DE 102005009217A DE 102005009217 A1 DE102005009217 A1 DE 102005009217A1
- Authority
- DE
- Germany
- Prior art keywords
- pain
- drug
- polymorph
- measured
- phosphoric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 0 CN(C)CC(CCC(*)(*)C1)C1(*)c1cc(O*)ccc1 Chemical compound CN(C)CC(CCC(*)(*)C1)C1(*)c1cc(O*)ccc1 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (35)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005009217A DE102005009217A1 (de) | 2005-02-25 | 2005-02-25 | Phosphatsalze der 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexanverbindungen |
TW095104476A TW200640840A (en) | 2005-02-25 | 2006-02-10 | Phosphatsalze der 6-dimethylaminomethyl-1-(3-methoxyphenyl)-1, 3-dihydroxy-cyclohexanverbindungen |
MX2007010192A MX2007010192A (es) | 2005-02-25 | 2006-02-21 | Formas cristalinas del clorhidrato de (1rs, 3rs, 6rs)-6-dimetilaminometil-1-(3-metoxi-fenil) ciclohexano-1, 3-diol. |
CA002598845A CA2598845A1 (en) | 2005-02-25 | 2006-02-21 | Phosphate salts of 6-dimethylaminomethyl-l-(3-methoxyphenyl)-1,3-dihydr oxy-cyclohexane compounds |
BRPI0606234-2A BRPI0606234A2 (pt) | 2005-02-25 | 2006-02-21 | formas cristalinas de cloridrato de (1rs,3rs,6rs)-6-dimetilaminometil-1-(3-metóxi-fenil) ciclo-hexano-1,3-diol |
MX2007010361A MX2007010361A (es) | 2005-02-25 | 2006-02-21 | Sales de fosfato de los compuestos de 6-dimetilaminometil-1(3-meto xifenil)-1, 3-dihidroxi-ciclohexano. |
JP2007556542A JP2008531510A (ja) | 2005-02-25 | 2006-02-21 | 6−ジメチルアミノメチル−1−(3−メトキシフェニル)−1,3−ジヒドロキシ−シクロヘキサン化合物のリン酸塩 |
KR1020077021974A KR20070107162A (ko) | 2005-02-25 | 2006-02-21 | 6-디메틸아미노메틸-1-(3-메톡시페닐)-1,3-디하이드록시사이클로헥산 화합물의 인산염 |
KR1020077021682A KR20070112812A (ko) | 2005-02-25 | 2006-02-21 | (1rs,3rs,6rs)-6-디메틸아미노메틸-1-(3-메톡시-페닐)사이클로헥산-1,3-디올 하이드로클로라이드의 결정질 형태 |
NZ560204A NZ560204A (en) | 2005-02-25 | 2006-02-21 | Crystalline forms of (1RS,3RS,6RS)-6-dimethylaminomethyl-1-(3-methoxy- phenyl)cyclohexane-1,3-diol hydrochloride |
PCT/EP2006/001548 WO2006089708A1 (en) | 2005-02-25 | 2006-02-21 | Crystalline forms of (1rs,3rs,6rs)-6-dimethvlaminomethvl-1-(3-methoxv- phenyl)cyclohexane-1 ,3-diol hydrochloride |
BRPI0606146-0A BRPI0606146A2 (pt) | 2005-02-25 | 2006-02-21 | compostos de sais fosfato 6-dimetilaminometil-1-(3-metoxifenil)-1,3-dihidroxicicl ohexano |
EP06707123A EP1851191A1 (de) | 2005-02-25 | 2006-02-21 | Phosphatsalze der 6-dimethylaminomethyl-l- (3-methoxyphenyl) -1,3-dihydroxy- cyclohexanverbindungen |
EP06707124A EP1851192A1 (en) | 2005-02-25 | 2006-02-21 | Crystalline forms of (1rs,3rs,6rs)-6-dimethvlaminomethvl-1-(3-methoxv- phenyl)cyclohexane-1 ,3-diol hydrochloride |
CN2006800062321A CN101128417B (zh) | 2005-02-25 | 2006-02-21 | (1rs,3rs,6rs)-6-二甲氨基甲基-1-(3-甲氧基-苯基)环己烷-1,3-二醇盐酸盐的晶形 |
CNA2006800059649A CN101137615A (zh) | 2005-02-25 | 2006-02-21 | 6-二甲基氨基甲基-1-(3-甲氧基苯基)-1,3-二羟基-环己烷化合物的磷酸盐 |
AU2006218132A AU2006218132B2 (en) | 2005-02-25 | 2006-02-21 | Phosphate salts of 6-dimethylaminomethyl-l-(3-methoxyphenyl) -1,3-dihydroxycyclohexane compounds |
US11/885,039 US8309610B2 (en) | 2005-02-25 | 2006-02-21 | Crystalline forms of (1RS,3RS,6RS)-6-dimethylaminomethyl-1-(3-methoxyphenyl)cyclohexane-1,3-diol hydrochloride |
NZ556338A NZ556338A (en) | 2005-02-25 | 2006-02-21 | Phosphate salts of 6-dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexane compounds |
JP2007556543A JP2008531511A (ja) | 2005-02-25 | 2006-02-21 | (1rs,3rs,6rs)−6−ジメチルアミノメチル−1−(3−メトキシ−フェニル)シクロヘキサン−1,3−ジオール塩酸塩の結晶形 |
AU2006218133A AU2006218133B8 (en) | 2005-02-25 | 2006-02-21 | Crystalline forms of (1RS,3RS,6RS)-6-Dimethvlaminomethyl-1-(3-methoxy- phenyl)cyclohexane-1 ,3-diol hydrochloride |
CA002598579A CA2598579A1 (en) | 2005-02-25 | 2006-02-21 | Crystalline forms of (1rs,3rs,6rs)-6-dimethvlaminomethvl-1-(3-methoxv- phenyl)cyclohexane-1 ,3-diol hydrochloride |
RU2007135271/04A RU2007135271A (ru) | 2005-02-25 | 2006-02-21 | Фосфатные соли 6-диметиламинометил-1-(3-метоксифенил)-1, 3-дигидрооксициклогексановых соединений |
RU2007135270/04A RU2007135270A (ru) | 2005-02-25 | 2006-02-21 | Кристаллические модификации гидрохлорида (1rs,3rs,6rs)-6-диметиламиноиетил-1-(3-метоксифенил)циклогексан-1,3-диола |
PCT/EP2006/001547 WO2006089707A1 (de) | 2005-02-25 | 2006-02-21 | Phosphatsalze der 6-dimethylaminomethyl-l- (3-methoxyphenyl) -1,3-dihydroxy- cyclohexanverbindungen |
ARP060100684A AR053145A1 (es) | 2005-02-25 | 2006-02-24 | Sales de fosfato del compuesto 6-dimetilaminometil-1 (3-metoxifenil)-1,3-hidroxi-ciclohexano |
US11/361,954 US20060211887A1 (en) | 2005-02-25 | 2006-02-27 | Phosphate salts of 6-dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexane compounds |
PE2006000228A PE20061100A1 (es) | 2005-02-25 | 2006-02-27 | Sales de fosfato de 6-dimetilaminometil-1-(3-metoxifenil)-1,3-dihidroxicliclohexano |
IL185468A IL185468A0 (en) | 2005-02-25 | 2007-08-23 | Phosphate salts of 6-dimethylaminomethyl-l -(3-methoxyphenyl)-1,3-dihydroxy cyclohexane compounds |
IL185467A IL185467A0 (en) | 2005-02-25 | 2007-08-23 | Crystalline forms of (1rs,3rs,6rs)-6-dimethylaminomethyl-1-(3-methoxy-phenyl) cyclohexane-1,3-diol hydrochloride |
NO20074673A NO20074673L (no) | 2005-02-25 | 2007-09-13 | Fosfatsalter av 6-dimetylaminometyl-L-(3-metoksyfenyl)1,3,dihydroksycykloheksanforbindelser |
NO20074676A NO20074676L (no) | 2005-02-25 | 2007-09-13 | Krystallinske former av (1 RS, 3RS, 6RS)-6-dimetylaminometyl-1-(3-metoksy-fenyl)cykloheksan-1,3-diol hydroklorid |
ZA200708153A ZA200708153B (en) | 2005-02-25 | 2007-09-21 | Phosphate salts of 6-dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxycyclohexane |
IL212291A IL212291A0 (en) | 2005-02-25 | 2011-04-13 | Crystalline form of (1rs,3rs,6rs)-6-dimethylaminomethyl-1-(3-methoxy-phenyl) cyclohexane-1,3-diol hydrochloride, pharmaceutical compositions comprising it and a process for its preparation |
IL212292A IL212292A0 (en) | 2005-02-25 | 2011-04-13 | Crystalline form of (1rs,3rs,6rs)-6-dimethylaminomethyl-1-(3-methoxy-phenyl) cyclohexane-1,3-diol hydrochloride, a proess, for its preparation and pharmaceutical compositions comprising it |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005009217A DE102005009217A1 (de) | 2005-02-25 | 2005-02-25 | Phosphatsalze der 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexanverbindungen |
Publications (1)
Publication Number | Publication Date |
---|---|
DE102005009217A1 true DE102005009217A1 (de) | 2006-08-31 |
Family
ID=36090780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE102005009217A Withdrawn DE102005009217A1 (de) | 2005-02-25 | 2005-02-25 | Phosphatsalze der 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexanverbindungen |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1851191A1 (ko) |
JP (1) | JP2008531510A (ko) |
KR (1) | KR20070107162A (ko) |
CN (1) | CN101137615A (ko) |
AR (1) | AR053145A1 (ko) |
AU (1) | AU2006218132B2 (ko) |
BR (1) | BRPI0606146A2 (ko) |
CA (1) | CA2598845A1 (ko) |
DE (1) | DE102005009217A1 (ko) |
IL (1) | IL185468A0 (ko) |
MX (1) | MX2007010361A (ko) |
NO (1) | NO20074673L (ko) |
NZ (1) | NZ556338A (ko) |
PE (1) | PE20061100A1 (ko) |
RU (1) | RU2007135271A (ko) |
TW (1) | TW200640840A (ko) |
WO (1) | WO2006089707A1 (ko) |
ZA (1) | ZA200708153B (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008138558A1 (de) * | 2007-05-11 | 2008-11-20 | Grünenthal GmbH | Axomadol zur schmerzbehandlung bei arthrose |
WO2011029614A1 (en) * | 2009-09-14 | 2011-03-17 | Grünenthal GmbH | Crystalline modifications of 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007008752A2 (en) | 2005-07-07 | 2007-01-18 | Farnam Companies, Inc. | Sustained release pharmaceutical compositions for highly water soluble drugs |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0753506B1 (de) * | 1995-07-11 | 1999-08-18 | Grünenthal GmbH | 6-Dimethylaminomethyl-1-phenyl-cyclo-hexanverbindungen als pharmazeutische Wirkstoffe |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10146275A1 (de) * | 2001-09-18 | 2003-04-24 | Gruenenthal Gmbh | Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz |
DE10333835A1 (de) * | 2003-07-24 | 2005-03-10 | Gruenenthal Gmbh | 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol enthaltendes Arzneimittel mit verzögerter Wirkstofffreisetzung |
-
2005
- 2005-02-25 DE DE102005009217A patent/DE102005009217A1/de not_active Withdrawn
-
2006
- 2006-02-10 TW TW095104476A patent/TW200640840A/zh unknown
- 2006-02-21 RU RU2007135271/04A patent/RU2007135271A/ru not_active Application Discontinuation
- 2006-02-21 JP JP2007556542A patent/JP2008531510A/ja not_active Withdrawn
- 2006-02-21 WO PCT/EP2006/001547 patent/WO2006089707A1/de active Application Filing
- 2006-02-21 BR BRPI0606146-0A patent/BRPI0606146A2/pt not_active IP Right Cessation
- 2006-02-21 MX MX2007010361A patent/MX2007010361A/es not_active Application Discontinuation
- 2006-02-21 AU AU2006218132A patent/AU2006218132B2/en not_active Ceased
- 2006-02-21 EP EP06707123A patent/EP1851191A1/de not_active Withdrawn
- 2006-02-21 CN CNA2006800059649A patent/CN101137615A/zh active Pending
- 2006-02-21 KR KR1020077021974A patent/KR20070107162A/ko not_active Application Discontinuation
- 2006-02-21 CA CA002598845A patent/CA2598845A1/en not_active Abandoned
- 2006-02-21 NZ NZ556338A patent/NZ556338A/en not_active IP Right Cessation
- 2006-02-24 AR ARP060100684A patent/AR053145A1/es not_active Application Discontinuation
- 2006-02-27 PE PE2006000228A patent/PE20061100A1/es not_active Application Discontinuation
-
2007
- 2007-08-23 IL IL185468A patent/IL185468A0/en unknown
- 2007-09-13 NO NO20074673A patent/NO20074673L/no not_active Application Discontinuation
- 2007-09-21 ZA ZA200708153A patent/ZA200708153B/xx unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0753506B1 (de) * | 1995-07-11 | 1999-08-18 | Grünenthal GmbH | 6-Dimethylaminomethyl-1-phenyl-cyclo-hexanverbindungen als pharmazeutische Wirkstoffe |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008138558A1 (de) * | 2007-05-11 | 2008-11-20 | Grünenthal GmbH | Axomadol zur schmerzbehandlung bei arthrose |
WO2011029614A1 (en) * | 2009-09-14 | 2011-03-17 | Grünenthal GmbH | Crystalline modifications of 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol |
Also Published As
Publication number | Publication date |
---|---|
AU2006218132B2 (en) | 2011-10-06 |
BRPI0606146A2 (pt) | 2009-06-02 |
CA2598845A1 (en) | 2006-08-31 |
CN101137615A (zh) | 2008-03-05 |
NZ556338A (en) | 2009-11-27 |
TW200640840A (en) | 2006-12-01 |
WO2006089707A1 (de) | 2006-08-31 |
AR053145A1 (es) | 2007-04-25 |
EP1851191A1 (de) | 2007-11-07 |
MX2007010361A (es) | 2008-02-21 |
KR20070107162A (ko) | 2007-11-06 |
PE20061100A1 (es) | 2007-01-04 |
AU2006218132A1 (en) | 2006-08-31 |
RU2007135271A (ru) | 2010-02-27 |
IL185468A0 (en) | 2008-01-06 |
ZA200708153B (en) | 2008-10-29 |
JP2008531510A (ja) | 2008-08-14 |
NO20074673L (no) | 2007-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60205742T2 (de) | Tartratsalze von 5,8,14-Triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaen | |
EP2240431B1 (de) | Kristalline modifikationen von (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol | |
DE102007021043A1 (de) | Alpha-Form von Imatinib Mesylat und Verfahren zu seiner Herstellung | |
EP1690536A2 (de) | Verwendung von r-(+)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxy-methyl-Phenylisobuttersäureester Hydrogenfumarat zur Behandlung von Harndrang-Inkontinenz und anderen spasmogenen Leiden | |
DE60205888T2 (de) | Das citratsalz von 5,8,14-triazatetracyclo(10.3.1.02,11.04.9)-hexadeca-2(11),3,5,7,9-pentaen | |
CH696665A5 (de) | Racemisches Tamsulosin in Form einer freien Base und Verfahren zu deren Herstellung. | |
DE01988460T1 (de) | Kristalline venlafaxinbase und neue venlafaxin-hydrochlorid-modifikationen sowie verfahren zu deren herstellung | |
DE102005009217A1 (de) | Phosphatsalze der 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexanverbindungen | |
WO2004054971A1 (de) | Verfaren zur herstellung des r,r (oder s,s) konfugurierten glycopyrronium-stereoisomers | |
DE60006097T2 (de) | Hochreine (1r, 2s, 4r)-(-)-2-[(2'-(n,n-dimethylamino)-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptan und ihre pharmazeutisch akzeptierbaren säure-additions-salze, verfahren zu ihrer herstellung sowie sie enthaltendes medikament. | |
DE69913955T2 (de) | Ein verbessertes synthese- und reinigungsverfahren für (r*,r*)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl) cyclohexanol hydrochlorid | |
EP1246791B1 (de) | Aminomethyl-phenyl-cyclohexanonderivate | |
DE602004009831T2 (de) | Verfahren zur gewinnung von tolterodin | |
EP1881956B1 (de) | 3-(2-(dimethylamino)methyl-(cyclohex-1-yl))phenol-maleat und dessen kristalline formen | |
DE102004039373A1 (de) | Para-Alkyl-substituierte N-(4-Hydroxy-3-methoxy-benzyl)-zimtsäureamide und deren Verwendung zur Herstellung von Arzneimitteln | |
DE60205504T2 (de) | Zitronensäure salz von einer therapeutischen verbindung und deren pharmazeutischen zusammensetzungen | |
US20060211887A1 (en) | Phosphate salts of 6-dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexane compounds | |
EP1907351A1 (de) | Hcl-polymorphe von 3 - ( 2- (dimethylamino) methyl- ( cyclohex-i-yl) ) phenol | |
DE69306694T2 (de) | Kristalle von Hydroxyphenylpropionsäure-ester und ihre Herstellung | |
EP1907350B1 (de) | Salz von fumarsäure und 3- (2-dimethylamino) methyl- ( cyclohex-1-yl) ) phenol un dessen kristalline formen | |
AT7563U1 (de) | Verfahren zur herstellung von optisch aktivem tamsulosin | |
AT7487U1 (de) | Racemisches tamsulosin als freie base sowie verfahren zur herstellung derselben | |
AT7562U1 (de) | (3-aminosulfonyl-4-methoxy)phenylaceton sowie dessen verwendung zur herstellung von racemischem tamsulosin | |
DD285344B5 (de) | Verfahren zur herstellung der reinen enantiomeren des 1-(4-nitrophenoxy)-2-hydroxy-3-(n-formyl-n-tert.-butyl)-aminopropan | |
WO2004065349A1 (de) | Medizinisch nützliche 1-phenyl-2-aminomethylnapthtaline, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OM8 | Search report available as to paragraph 43 lit. 1 sentence 1 patent law | ||
R005 | Application deemed withdrawn due to failure to request examination |
Effective date: 20120228 |